Effect of dietary fat modification on subcutaneous white adipose tissue insulin sensitivity in patients with metabolic syndrome

Molecular Nutrition and Food Research

Volumn 58, Issue 11, 2014, Pages 2177-2188

  Jimenez Gomez, Yolanda ^a   Cruz Teno, Cristina ^a   Rangel Zuñiga, Oriol A ^a   Peinado, Juan R ^a   Perez Martinez, Pablo ^a   Delgado Lista, Javier ^a   Garcia Rios, Antonio ^a   Camargo, Antonio ^a   Vazquez Martinez, Rafael ^a   Ortega Bellido, Maria ^a   Perez Jimenez, Francisco ^a   Roche, Helen M ^b   Malagon, Maria M ^a   Lopez Miranda, Jose ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Dietary fats; Glucose metabolism disorders; Insulin resistance; Metabolic syndrome; n 3 PUFA

Indexed keywords

ANXA2 PROTEIN, HUMAN; CARBOHYDRATE DIET; CHAPERONE; CLN3 PROTEIN, HUMAN; FAT INTAKE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INSULIN; LIPOCORTIN 2; MEMBRANE PROTEIN; MESSENGER RNA; MONOUNSATURATED FATTY ACID; UNSATURATED FATTY ACID;

ADMINISTRATION AND DOSAGE; BLOOD; BLOOD PRESSURE; BODY MASS; CARBOHYDRATE DIET; CONTROLLED STUDY; DIET; FAT INTAKE; GENETICS; HUMAN; INSULIN RESISTANCE; LIFESTYLE; MASS SPECTROMETRY; METABOLIC SYNDROME X; METABOLISM; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS FAT; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ANNEXIN A2; BLOOD PRESSURE; BODY MASS INDEX; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, UNSATURATED; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; INSULIN; INSULIN RESISTANCE; LIFE STYLE; MEMBRANE GLYCOPROTEINS; METABOLIC SYNDROME X; MOLECULAR CHAPERONES; RNA, MESSENGER; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBCUTANEOUS FAT;

EID: 84922706056     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300901     Document Type: Article

References (52)

1. Phillips, C., Lopez-Miranda, J., Perez-Jimenez, F., McManus, R. et al., Genetic and nutrient determinants of the metabolic syndrome. Curr. Opin. Cardiol. 2006, 21, 185-193.
2. Pereira, M. A., Jacobs, D. R. Jr., Van Horn, L., Slattery, M. L. et al., Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA 2002, 287, 2081-2089.
3. Kahn, B. B., Flier, J. S., Obesity and insulin resistance. J. Clin. Invest. 2000, 106, 473-481.
4. Poirier, P., Giles, T. D., Bray, G. A., Hong, Y. et al., Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006, 113, 898-918.
5. Olefsky, J. M., Glass, C. K., Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 2010, 72, 219-246.
6. Schenk, S., Saberi, M., Olefsky, J. M., Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest. 2008, 118, 2992-3002.
7. Saltiel, A. R., Kahn, C. R., Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414, 799-806.
8. Gao, Z., Hwang, D., Bataille, F., Lefevre, M. et al., Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J. Biol. Chem. 2002, 277, 48115-48121.
9. Tian, R., Another role for the celebrity: Akt and insulin resistance. Circ. Res. 2005, 96, 139-140
10. Colomiere, M., Permezel, M., Lappas, M., Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue. J. Mol. Endocrinol. 2010, 44, 213-223.
11. Baumann, C. A., Chokshi, N., Saltiel, A. R., Ribon, V., Cloning and characterization of a functional peroxisome proliferator activator receptor-gamma-responsive element in the promoter of the CAP gene. J. Biol. Chem. 2000, 275, 9131-9135.
12. Guilherme, A., Soriano, N. A., Bose, S., Holik, J. et al., EHD2 and the novel EH domain binding protein EHBP1 couple endocytosis to the actin cytoskeleton. J. Biol. Chem. 2004, 279, 10593-10605.
13. Roche, H. M., Fatty acids and the metabolic syndrome. Proc. Nutr. Soc. 2005, 64, 23-29.
14. Storlien, L. H., Baur, L. A., Kriketos, A. D., Pan, D. A. et al., Dietary fats and insulin action. Diabetologia 1996, 39, 621-631.
15. Vessby, B., Uusitupa, M., Hermansen, K., Riccardi, G. et al., Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy en and women: the KANWU Study. Diabetologia 2001, 44, 312-319.
16. Pérez-Jiménez, F., López-Miranda, J., Pinillos, M. D., Gómez, P. et al., A Mediterranean and a high-carbohydrate diet improve glucose metabolism in healthy young persons. Diabetologia 2001, 44, 2038-2043.
17. Vega-López, S., Ausman, L. M., Jalbert, S. M., Erkkilä, A.T. et al., Palm and partially hydrogenated soybean oils adversely alters lipoprotein profiles compared with soybean and canola oils in moderately hyperlipidemic subjects. Am. J. Clin. Nutr. 2006, 84, 54-62.
18. Griffin, M. D., Sanders, T. A., Davies, I. G., Morgan, L. M. et al., Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study. Am. Clin. J. Nutr. 2006, 84, 1290-1298.
19. Kabir, M., Skurnik, G., Naour, N., Pechtner, V. et al., Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am. J. Clin. Nutr. 2007, 86, 1670-1679.
20. Roche, H. M., Gibney, M. J., Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism. Am. J. Clin. Nutr. 2000, 71, 232S-237S.
21. Paniagua, J. A., Pérez-Martinez, P., Gjelstad, I. M., Tierney, A. C. et al., LIPGENE Study Investigators. A low-fat high-carbohydrate diet supplemented with long-chain n-3 PUFA reduces the risk of the metabolic syndrome. Atherosclerosis 2011, 218, 443-450.
22. Hartwich, J., Malec, M. M., Partyka, L., Pérez-Martinez, P. et al., The effect of the plasma n-3/n-6 polyunsaturated fatty acid ratio on the dietary LDL phenotype transformation-insights from the LIPGENE study. Clin. Nutr. 2009, 28, 510-515.
23. Tierney, A. C., McMonagle, J., Shaw, D. I., Gulseth, H. L. et al., Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome-LIPGENE: a European randomized dietary intervention study. Int. J. Obes. (Lond). 2011, 35, 800-809.
24. Shaw, D. I., Tierney, A. C., McCarthy, S., Upritchard, J. et al., LIPGENE food-exchange model for alteration of dietary fat quantity and quality in free-living participants from eight European countries. Br. J. Nutr. 2009, 101, 750-759.
25. Grundy, S. M., Brewer, H. B. Jr., Cleeman, J. I., Smith, S. C. Jr. et al., National Heart, Lung, and Blood Institute, American Heart Association. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler. Thromb. Vasc. Biol. 2004, 24, e13-e18.
26. Perez-Martinez, P., Moreno-Conde, M., Cruz-Teno, C., Ruano, J. et al., Dietary fat differentially influences regulatory endothelial function during postprandial state in patients with metabolic syndrome: from the LIPGENE study. Atherosclerosis 2010, 209, 533-538.
27. Peinado, J. R., Jimenez-Gomez, Y., Pulido, M. R., Ortega-Bellido, M. et al., The stromal-vascular fraction of adipose tissue contributes to mayor differences between subcutaneous and visceral fat depots. Proteomics 2010, 10, 3356-3366.
28. Cruz-Teno, C., Pérez-Martínez, P., Delgado-Lista, J., Yubero-Serrano, E. M. et al., Dietary fat modifies the postprandial inflammatory state in subjects with metabolic syndrome: the LIPGENE study. Mol. Nutr. Food Res. 2012, 56, 854-865.
29. Ramel, A., Martinez, A., Kiely, M., Morais, G. et al., Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults. Diabetologia 2008, 51, 1261-1268.
30. Spadaro, L., Magliocco, O., Spampinato, D., Piro, S. et al., Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig. Liver Dis. 2008, 40, 194-99.
31. Hartweg, J., Perera, R., Montori, V., Dinneen, S. et al., Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 2008, 23, CD003205.
32. International Diabetes Federation, The IDF consensus worldwide definition of the metabolic syndrome. 2005. Available from: www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf.
33. Eckel, R. H., Grundy, S. M., Zimmet, P. Z., The metabolic syndrome. Lancet 2005, 365, 1415-1428.
34. Ozes, O. N., Akca, H., Mayo, L. D., Gustin, J. A. et al., A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc. Natl. Acad. Sci. USA 2001, 98, 4640-4645.
35. Ribon, V., Johnson, J. H., Camps, H. S., Saltiel, A. R., Thiazolidinediones and insulin resistance: peroxisome proliferator activated receptor gamma activation stimulates expression of the CAP gene. Proc. Natl. Acad. Sci. USA 1998, 95, 14751-14756.
36. Le Lay, S., Lefrère, I., Trautwein, C., Dugail, I. et al., Insulin and sterol-regulatory element-binding protein-1c (SREBP-1C) regulation of gene expression in 3T3-L1 adipocytes. Identification of CCAAT/enhancer-binding protein beta as an SREBP-1C target. J. Biol. Chem. 2002, 277, 35625-35634.
37. Min, J., Kyung Kim, Y., Cipriani, P. G., Kang, M. et al., Forward chemical genetic approach identifies new role for GAPDH in insulin signaling. Nat. Chem. Biol. 2007, 3, 55-59.
38. Dugail, I., Quignard-Boulange, A., Bazin, R., Le Liepvre, X. et al., Adipose-tissue-specific increase in glyceraldehyde-3-phosphate dehydrogenase activity and mRNA amounts in suckling pre-obese Zucker rats. Effect of weaning. Biochem. J. 1998, 254, 483-487.
39. Liu, Y. M., Lacorte, J. M., Viquerie, N., Poitou, C. et al., Adiponectin gene expression in subcutaneous adipose tissue of obese women in response to short-term very low calorie diet and refeeding. J. Clin. Endocrinol. Metab. 2003, 88, 5881-5886.
40. Holyoak, T., Sullivan, S. M., Nowak, T., Structural insights into the mechanism of PEPCK catalysis. Biochemistry 2006, 45, 8254-8263.
41. Beale, E. G., Hammer, R. E., Antoine, B., Forest, C., Dysregulated glyceroneogenesis: PCK1 as a candidate diabetes and obesity gene. Trends Endocrinol. Metab. 2004, 15, 129-135.
42. Millward, C. A., Desantis, D., Hsieh, C. W., Heaney, J. D. et al., Phosphoenolpyruvate carboxykinase (Pck1) helps regulate the triglyceride/fatty acid cycle and development of insulin resistance in mice. J. Lipid. Res. 2010, 51, 1452-1463.
43. Leroyer, S. N., Tordjman, J., Chauvet, G., Quette, J. et al., Rosiglitazone controls fatty acid cycling in human adipose tissue by means of glyceroneogenesis and glycerol phosphorylation. J. Biol. Chem. 2006, 28, 13141-13149.
44. Franckhauser, S., Muñoz, S., Pujol, A., Casellas, A. et al., Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes 2002, 51, 624-630.
45. Franckhauser, S., Muñoz, S., Elias, I., Ferre, T. et al., Adipose overexpression of phosphoenolpyruvate carboxykinase leads to high susceptibility to diet-induced insulin resistance and obesity. Diabetes 2006, 55, 273-280.
46. Burgoyne, R. D., Geisow, M. J., The annexin family of calcium-binding proteins. Cell Calcium 1989, 10, 1-10.
47. Robitzki, A., Schröder, H. C., Ugarkovic, D., Gramzow, M. et al., cDNA structure and expression of calpactin, a peptide involved in Ca2(+)-dependent cell aggregation in sponges. Biochem. J. 1990, 271, 415-420.
48. Huang, J., Hsia, S. H., Imamura, T., Usui, I. et al., Annexin II is a thiazolidinedione-responsive gene involved in insulin-induced glucose transporter isoform 4 translocation in 3T3-L1 adipocytes. Endocrinology 2004, 145, 1579-1586.
49. Tanaka, T., Akatsuka, S., Ozeki, M., Shirase, T. et al., Redox regulation of annexin 2 and its implications for oxidative stress-induced renal cacinogenesis and metastasis. Oncogene 2004, 23, 3980-3989.
50. Kozak, L., Newman, S., Chao, P. M., Mendoza, T. et al., The early nutritional environment of mice determines the capacity for adipose tissue expansion by modulating genes of caveolae structure. PloS One 2010, 5, e11015.
51. Leggate, M., Carter, W. G., Evans, M. J., Vernnard, R. A. et al., Determination of inflammatory and prominent proteomic changes in plasma and adipose tissue after high-intensity intermittent training in overweight and obese males. J. Appl. Physiol. 2012, 112, 1353-1360.
52. Fan, C., Zirpoli, H., Qi, L., n-3 fatty acids modulate adipose tissue inflammation and oxidative stress. Curr. Opin. Clin. Nutr. Metab. Care 2013, 16, 124-132.